Melissa Borucki
Impact in
- Spectroscopy top 1%
- Advanced Proteomics Techniques and Applications
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
-
- Renal cell carcinoma treatment 4
- Lung Cancer Treatments and Mutations 1
-
- Endometrial and Cervical Cancer Treatments 2
- Journals
- Cell (7 papers)Cancer Cell (5 papers)Cell Reports Medicine (2 papers)Nature Cancer (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Melissa Borucki
14 papers receiving 3.8k citations
Melissa Borucki's Hit Papers
Peers
Comparison fields: 5 of 69
- Spectroscopy 573
- Genetics 217
- Oncology 498
- Cancer Research 259
- Pulmonary and Respiratory Medicine 341
Countries citing papers authored by Melissa Borucki
This map shows the geographic impact of Melissa Borucki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Borucki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Borucki more than expected).
Fields of papers citing papers by Melissa Borucki
This network shows the impact of papers produced by Melissa Borucki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Borucki. The network helps show where Melissa Borucki may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities Hit paper breakdown → | 2019 | 598 |
| 2 | Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma Hit paper breakdown → | 2020 | 584 |
| 3 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2019 | 554 |
| 4 | Proteogenomic and metabolomic characterization of human glioblastoma Hit paper breakdown → | 2021 | 467 |
| 5 | Proteogenomic characterization of pancreatic ductal adenocarcinoma Hit paper breakdown → | 2021 | 403 |
| 6 | Proteogenomic Characterization of Endometrial Carcinoma Hit paper breakdown → | 2020 | 356 |
| 7 | A proteogenomic portrait of lung squamous cell carcinoma Hit paper breakdown → | 2021 | 275 |
| 8 | Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma Hit paper breakdown → | 2021 | 257 |
| 9 | 2022 | 136 | |
| 10 | 2020 | 115 | |
| 11 | 2020 | 64 | |
| 12 | 2023 | 42 | |
| 13 | 2024 | 32 | |
| 14 | 2025 | 3 | |
| 15 | 2026 | 0 | |
| 16 | 2026 | 0 |
About Melissa Borucki
Melissa Borucki is a scholar working on Pulmonary and Respiratory Medicine, Obstetrics and Gynecology, Otorhinolaryngology, Genetics and Hematology, having authored 16 papers that have together received 3.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Endometrial and Cervical Cancer Treatments (2 papers), Lung Cancer Treatments and Mutations (1 paper), Head and Neck Cancer Studies (1 paper), Acute Myeloid Leukemia Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Glioma Diagnosis and Treatment (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Spectroscopy (573 citations), Genetics (217 citations), Oncology (498 citations), Cancer Research (259 citations) and Pulmonary and Respiratory Medicine (341 citations). Melissa Borucki has collaborated with scholars based in United States and Taiwan. Their work appears in journals such as Cell, Cancer Cell, Cell Reports Medicine, Nature Cancer and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.